Jordan Berlin
- Oncology top 0.02%
- Colorectal Cancer Treatments and Studies 118
- Pancreatic and Hepatic Oncology Research 100
- Cancer Treatment and Pharmacology 64
- HER2/EGFR in Cancer Research 25
- Hepatology top 0.2%
- Cancer Research top 0.1%
- Cancer Genomics and Diagnostics 47
- Pulmonary and Respiratory Medicine top 0.1%
- Gastric Cancer Management and Outcomes 52
- Lung Cancer Treatments and Mutations 44
- Pathology and Forensic Medicine top 0.2%
-
- Neuroendocrine Tumor Research Advances 44
- Co-authors
- Fairooz F. KabbinavarJohn D. HainsworthW. HeimHerbert I. HurwitzWilliam NovotnyLouis FehrenbacherEric HolmgrenThomas H. Cartwright
- Cited by
- OncologyHepatologyCancer Research
- Journals
- Journal of Clinical Oncology (108 papers)Annals of Oncology (25 papers)Investigational New Drugs (18 papers)
- Partner nations
- United StatesGermanySpain
In The Last Decade
Jordan Berlin
342 papers receiving 22.2k citations
Hit Papers
Peers
Comparison fields: 5 of 158
- Oncology 15.3k
- Hepatology 2.8k
- Cancer Research 5.0k
- Pulmonary and Respiratory Medicine 6.3k
- Pathology and Forensic Medicine 2.4k
Countries citing papers authored by Jordan Berlin
This map shows the geographic impact of Jordan Berlin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jordan Berlin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jordan Berlin more than expected).
Fields of papers citing papers by Jordan Berlin
This network shows the impact of papers produced by Jordan Berlin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jordan Berlin. The network helps show where Jordan Berlin may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jordan Berlin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 6 | |
| 2 | 2024 | 0 | |
| 3 | 2024 | 4 | |
| 4 | 2024 | 4 | |
| 5 | 2024 | 1 | |
| 6 | 2024 | 21 | |
| 7 | 2023 | 28 | |
| 8 | 2023 | 1 | |
| 9 | 2023 | 2 | |
| 10 | 2023 | 2 | |
| 11 | 2021 | 10 | |
| 12 | Phosphatidylinositol 3-Kinase α–Selective Inhibition With Alpelisib (BYL719) in PIK3CA-Altered Solid Tumors: Results From the First-in-Human Studybreakdown → | 2018 | 302 |
| 13 | 2017 | 139 | |
| 14 | 2015 | 26 | |
| 15 | 2014 | 78 | |
| 16 | 2013 | 74 | |
| 17 | 2012 | 143 | |
| 18 | The molecular evolution of acquired resistance to targeted EGFR blockade in colorectal cancersbreakdown → | 2012 | 1290 |
| 19 | 2011 | 74 | |
| 20 | 2011 | 35 |
About Jordan Berlin
Jordan Berlin is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine, having authored 357 papers that have together received 22.9k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (118 papers), Pancreatic and Hepatic Oncology Research (100 papers), Cancer Treatment and Pharmacology (64 papers), Gastric Cancer Management and Outcomes (52 papers), Cancer Genomics and Diagnostics (47 papers), Neuroendocrine Tumor Research Advances (44 papers), Lung Cancer Treatments and Mutations (44 papers) and HER2/EGFR in Cancer Research (25 papers). The work is most often cited by research in Oncology (15.3k citations), Hepatology (2.8k citations) and Cancer Research (5.0k citations). Jordan Berlin has collaborated with scholars based in United States, Germany and Spain. Frequent co-authors include Fairooz F. Kabbinavar, John D. Hainsworth, W. Heim, Herbert I. Hurwitz, William Novotny, Louis Fehrenbacher, Eric Holmgren, Thomas H. Cartwright, Napoleone Ferrara and Ari David Baron. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Investigational New Drugs, Cancer Research and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.